Bridges–Good Syndrome

Bridges–Good syndrome is another name for a rare illness called chronic granulomatous disease (CGD). In this disease, some white blood cells (called phagocytes) cannot make important “reactive oxygen” chemicals that usually help kill germs. Because of this problem, the immune system cannot clear some bacteria and fungi properly, so the body gets many serious infections and forms small lumps of immune cells called granulomas in organs like lungs, liver, bowel, skin, and lymph nodes.

In Bridges–Good syndrome, the basic problem is a fault in a protein group called NADPH oxidase inside phagocytes. This protein group normally makes superoxide and other strong chemicals that damage and kill germs. When NADPH oxidase does not work, the cells can still eat the germs, but they cannot finish the job of killing them, so infections keep coming back and can become life-threatening.

Bridges-Good syndrome is another name for chronic granulomatous disease (CGD), a rare inherited immune system disorder. In CGD, some white blood cells (phagocytes) cannot produce the “reactive oxygen” chemicals they normally use to kill certain bacteria and fungi, because a key enzyme system called NADPH-oxidase does not work properly. As a result, people develop repeated serious infections and clusters of inflamed immune cells called granulomas in organs such as the lungs, liver, skin, lymph nodes, gut and bones.

Most people with Bridges–Good syndrome are diagnosed in childhood, often before 5 years of age, because they have repeated infections such as pneumonia, skin abscesses, swollen lymph nodes, or liver abscess. Without treatment, many children in the past died young, but now, with better antibiotics, antifungal drugs, and special treatments like interferon-gamma and stem cell transplant, many patients can live into adult life.

CGD is rare. It affects roughly 1 in 200,000–250,000 people in some Western countries. It occurs in boys more often than girls because the commonest form is linked to the X (sex) chromosome. However, there are also autosomal recessive forms that affect both boys and girls.

Other names

Doctors use several different names for the same disease. Bridges–Good syndrome is also called:

• Chronic granulomatous disease (CGD)

• Chronic granulomatous disorder

• Chronic septic granulomatosis

• Quie syndrome

• Congenital dysphagocytosis

These names all describe the same basic problem: chronic (long-term) granuloma-forming disease due to a phagocyte killing defect. Early reports described it as a “fatal granulomatous disease of childhood,” but now outcomes are better due to modern care.

Main clinical and genetic types 

• X-linked CGD (Bridges–Good syndrome classic form) – Caused by mutations in the CYBB gene on the X chromosome, which codes for the gp91phox subunit of NADPH oxidase. This is the most common type and mainly affects males.

• Autosomal recessive CGD due to CYBA mutation – Fault in the p22phox subunit. Both parents usually carry one faulty copy but are healthy; the child gets both copies and develops disease.

• Autosomal recessive CGD due to NCF1 mutation – Fault in p47phox; often seen in families or populations where parents are related (consanguineous marriage).

• Autosomal recessive CGD due to NCF2 mutation – Fault in p67phox, another part of the NADPH oxidase complex, again passed in a recessive pattern.

• Autosomal recessive CGD due to NCF4 mutation – Fault in p40phox, usually causing milder or variable symptoms but still leading to recurrent infections.

• Variant or “residual function” CGD – Gene changes that allow a small amount of NADPH oxidase activity. These patients may have later onset, milder infections, or atypical symptoms but still have the same basic disease mechanism.

Causes

Here “cause” means reasons why someone develops Bridges–Good syndrome. The main cause is inherited gene changes, but we can look at these in more detail.

1. Mutation in CYBB gene (gp91phox, X-linked)
   The most common cause is a harmful change in the CYBB gene on the X chromosome. This gene tells cells how to make the gp91phox protein, a key part of NADPH oxidase. When the gene is faulty, gp91phox does not work, so phagocytes cannot make the burst of reactive oxygen needed to kill germs.

2. Mutation in CYBA gene (p22phox)
   Some patients have harmful changes in CYBA, which codes for p22phox. This protein partners with gp91phox in the cell membrane. When p22phox is faulty, the whole oxidase complex cannot assemble, so germ-killing fails even if other parts are normal.

3. Mutation in NCF1 gene (p47phox)
   The NCF1 gene makes p47phox, a cytosolic protein that moves to the cell membrane during activation. Mutations in NCF1 stop p47phox from working, so the oxidase complex does not switch on properly, leading to frequent infections from childhood.

4. Mutation in NCF2 gene (p67phox)
   The NCF2 gene codes for p67phox, another helper protein for NADPH oxidase. When NCF2 is mutated, phagocytes cannot start the oxidative burst, so bacteria and fungi survive inside the cell and spread.

5. Mutation in NCF4 gene (p40phox)
   The NCF4 gene makes p40phox. This protein helps control the oxidase in certain cell compartments. Faulty p40phox can cause a less typical, sometimes milder CGD, but the basic problem—poor killing of germs—remains.

6. Other rare NADPH oxidase-related gene defects
   Rare families have gene changes in other parts of the oxidase system or in regulators that control assembly and activity. These defects all reduce reactive oxygen species production and lead to CGD-like disease.

7. X-linked inheritance from a carrier mother
   In the typical X-linked form, the mother carries one faulty CYBB gene and one normal gene, often without symptoms. A male child who gets the faulty X will develop CGD because he has no second normal X to protect him.

8. Autosomal recessive inheritance from both parents
   For autosomal recessive CGD (CYBA, NCF1, NCF2, NCF4), each parent carries one faulty and one normal copy. They are healthy, but when a child gets both faulty copies, NADPH oxidase fails and Bridges–Good syndrome appears.

9. New (de novo) gene mutations
   Sometimes, a child has a gene change that is not present in either parent. This new mutation, happening in a sperm or egg cell or early embryo, can still fully disrupt NADPH oxidase and cause CGD.

10. Parents who are blood relatives (consanguinity)
    In populations where marriage between close relatives is common, there is a higher chance that both parents carry the same recessive CGD gene change, so their children have a higher risk of disease.

11. Low NADPH levels due to other enzyme defects (e.g., severe G6PD deficiency)
    Very low NADPH supply, such as in rare severe forms of glucose-6-phosphate dehydrogenase (G6PD) deficiency, can also lead to CGD-like problems, because NADPH is the fuel for the oxidase system that makes reactive oxygen.

12. Male sex (for X-linked type)
    Because the commonest form is X-linked, boys are more often affected. Girls can be carriers or, rarely, have symptoms if both X chromosomes are affected or X inactivation is skewed.

13. Positive family history of early severe infections
    If there are brothers, cousins, or uncles who had repeated severe infections in childhood, the chance of a hidden CGD gene in the family is higher. This family pattern is itself a risk clue and reflects inherited mutations.

14. Geographic or ethnic clustering
    Certain regions and ethnic groups report more CGD cases, often linked to higher rates of consanguinity or founder mutations (a specific gene change passed down in a community).

15. Defective assembly of NADPH oxidase complex
    Even when all subunits are present, some gene variants affect how the proteins come together in the cell membrane. Poor assembly means the complex cannot work, so superoxide is not produced and germs survive.

16. Defects in signaling pathways that activate NADPH oxidase
    Some gene changes interfere with the signals that tell phagocytes to turn on the oxidase. When activation signals fail, the oxidative burst is weak or absent, leading to Bridges–Good syndrome features.

17. “Variant CGD” with partial oxidase activity
    Certain mutations produce a NADPH oxidase that works a little but not enough. People with such “variant CGD” still have recurrent infections and granulomas, especially under stress or heavy germ exposure.

18. Heavy early exposure to typical CGD pathogens in a susceptible child
    Children with a gene defect may show disease earlier if they meet organisms such as Staphylococcus aureus, Serratia marcescens, Burkholderia, Nocardia, or Aspergillus, which are classic problem germs in CGD.

19. Granuloma-driven organ damage as a secondary cause of symptoms
    The primary cause is genetic, but granuloma formation in bowel, urinary tract, or airways can itself cause further disease such as obstruction, pain, and malabsorption. This is a consequence of the underlying gene defect.

20. Lack of early diagnosis and prophylaxis (worsening expression)
    Not a cause of the gene defect, but a cause of more severe clinical disease. Without early recognition and preventive treatment, infections are more frequent and damage is greater in someone who already has the genetic problem.

Symptoms and signs

1. Repeated serious infections
   The main sign of Bridges–Good syndrome is recurrent bacterial and fungal infections, often needing strong hospital treatment. Children may have several serious infections each year, more than other children, because their phagocytes cannot kill certain germs well.

2. Pneumonia and lung infections
   Many patients get pneumonia, lung abscesses, or granulomas in the lungs. Symptoms include cough, fever, chest pain, and shortness of breath. These lung problems may keep coming back with different germs.

3. Skin abscesses and deep tissue abscesses
   Painful, warm, red lumps full of pus can form in the skin, liver, spleen, or other organs. These abscesses heal slowly and often return because the immune system cannot fully clear the infection.

4. Swollen lymph nodes (lymphadenitis)
   Lymph nodes in the neck, armpit, or groin may become large, tender, and painful during infections, as they fill with immune cells and sometimes pus. This happens because germs and granulomas collect in these glands.

5. Liver abscess and liver problems
   The liver is a common site of infection in CGD. Patients may have fever, pain in the upper right belly, weight loss, and abnormal liver blood tests when a liver abscess forms.

6. Bone infections (osteomyelitis)
   Germs can infect bones, especially in arms and legs, causing osteomyelitis. This leads to bone pain, swelling, trouble walking, and sometimes fractures or deformity if not treated quickly.

7. Chronic diarrhea and abdominal pain
   Up to half of patients have gut symptoms such as long-lasting diarrhea, abdominal pain, and bloating. The bowel lining can become inflamed and form granulomas, sometimes looking like inflammatory bowel disease.

8. Failure to thrive and poor weight gain
   Because of repeated infections and bowel problems, many children with Bridges–Good syndrome do not grow well. They may be shorter and lighter than other children their age and may look thin or tired.

9. Fever and chills
   Fever is a very common sign during infections or inflammatory flares. Caregivers may notice high temperature, sweating, and chills that do not settle easily, which should always be taken seriously in a patient with CGD.

10. Tiredness and weakness
    Ongoing infections, inflammation, anemia, and poor nutrition can cause chronic fatigue. Patients may feel weak, have low energy, and find it hard to keep up with daily activities or school.

11. Enlarged liver and spleen (hepatosplenomegaly)
    The liver and spleen may become large as they store immune cells and granulomas. Doctors may feel these organs below the ribs during an examination, and scans often confirm the enlargement.

12. Urinary or bowel blockage from granulomas
    Granulomas can form in the bowel, bladder, or urinary tract, causing blockage. This can lead to constipation, difficulty passing urine, belly pain, vomiting, or infections above the blockage.

13. Mouth and gum problems
    Some patients have repeated mouth ulcers, gum infections, or dental problems because bacteria in the mouth are harder to control. Eating and brushing teeth may be painful during flares.

14. Inflammatory bowel disease-like colitis
    In addition to infection, some patients develop auto-inflammatory colitis that looks like Crohn’s disease or ulcerative colitis on colonoscopy. This shows that Bridges–Good syndrome involves not only infection risk but also abnormal inflammation.

15. Slow healing and long-lasting scars
    Wounds, surgical cuts, and abscess drainage sites may heal slowly and leave firm, raised scars because the body constantly tries to wall off germs with granulomas instead of fully clearing them.

Diagnostic tests

Doctors usually suspect Bridges–Good syndrome when a child or adult has repeated unusual infections. They then use a group of tests to confirm the diagnosis, look for complications, and plan treatment.

A. Physical examination tests

1. Full physical examination and medical history
   The doctor asks detailed questions about past infections, hospital stays, family history, and growth, and then examines the whole body for fever, weight, height, skin lesions, enlarged lymph nodes, and organ enlargement. This first step guides which specific tests to do next.

2. Growth and nutrition assessment
   Measuring height, weight, and body mass index over time helps detect failure to thrive, which is common in CGD. Poor growth suggests long-standing disease and possible gut involvement.

3. Skin, lymph node, and joint examination
   The doctor checks the skin for abscesses, rashes, or scars; feels the lymph nodes for swelling; and checks joints for swelling or tenderness. These findings can show active infection or past granulomatous inflammation.

4. Abdominal and organ examination
   The doctor gently presses on the abdomen to look for enlarged liver and spleen and for tender areas suggesting bowel or liver disease. This simple exam is important to decide if imaging is needed quickly.

B. Manual / bedside tests

5. Vital signs (temperature, pulse, breathing rate, blood pressure)
   Repeated checks of temperature and other vital signs help show how severe an infection is and whether the patient is stable or in danger of sepsis. This is done at the bedside with simple devices.

6. Lung examination with a stethoscope
   Listening to the chest helps detect crackles, wheezes, or reduced air entry that point to pneumonia, lung abscess, or granulomas. This guides urgent imaging such as chest X-ray or CT.

7. Bedside inspection of stool or wound discharge
   Looking at stool for blood or mucus, and at wound or abscess drainage for pus, gives quick clues about bowel inflammation or active infection and supports the decision to send samples for laboratory culture.

C. Laboratory and pathological tests

8. Complete blood count (CBC) with differential
   A CBC looks at red cells, white cells, and platelets. In CGD, the number of neutrophils can be normal or high, but the function is poor. Anemia and high inflammatory markers are common during infection.

9. Inflammatory markers (ESR, CRP)
   Tests like ESR (erythrocyte sedimentation rate) and CRP (C-reactive protein) show levels of inflammation in the body. High values support the presence of infection or active granulomatous disease.

10. Blood cultures for bacteria and fungi
    Blood samples are taken and kept in special bottles to grow bacteria or fungi. Finding a germ in the blood confirms a serious infection and helps pick the best antibiotic or antifungal drug.

11. Culture of pus or tissue from abscesses
    Pus from skin, liver, or other abscesses is sent to the lab to see which organisms are present. Typical CGD pathogens such as Staphylococcus aureus, Serratia, Nocardia, and Aspergillus may be found.

12. Stool culture and parasite tests
    For patients with long-term diarrhea, stool is tested for bacteria, parasites, and sometimes viruses. This helps separate infection from purely inflammatory colitis and guides treatment.

13. Nitroblue tetrazolium (NBT) test
    The NBT test is a classic screening test for CGD. It measures whether neutrophils can change a yellow dye (NBT) into a dark blue compound when activated. In Bridges–Good syndrome, this color change is absent or greatly reduced.

14. Dihydrorhodamine (DHR) flow cytometry test
    The DHR test is now the main diagnostic test in many centers. Neutrophils are stimulated in the lab and exposed to dihydrorhodamine. Normal cells light up strongly when measured by a flow cytometer; CGD cells show little or no signal. This test is very sensitive and can also detect carriers.

15. Genetic testing for CGD genes
    DNA from blood is tested for harmful changes in CYBB, CYBA, NCF1, NCF2, NCF4, and sometimes other related genes. Genetic testing confirms the diagnosis, shows the exact type, and helps with family counseling and carrier testing.

16. Biopsy and histology of granulomas or bowel lesions
    A small piece of tissue from skin, lymph node, bowel, or another site is taken and examined under a microscope. CGD typically shows granulomas and chronic inflammation, sometimes with trapped germs. This helps rule out cancer or other diseases.

D. Electrodiagnostic and monitoring tests

17. Pulse oximetry (oxygen saturation monitoring)
    A small clip on the finger measures blood oxygen levels. In pneumonia or severe infection, the oxygen level may drop. While it does not diagnose CGD itself, it shows how sick the lungs and circulation are.

18. Electrocardiogram (ECG)
    An ECG records the electrical activity of the heart. During severe sepsis or when strong medicines are used, ECG helps check heart rhythm and function. It supports safe care in seriously ill CGD patients.

E. Imaging tests

19. Chest X-ray
    A chest X-ray is usually the first imaging test. It can show pneumonia, lung abscesses, or granulomas. In CGD, doctors often see recurrent or unusual patterns of lung infection that suggest an immune problem.

20. CT scan, MRI, or ultrasound of organs
    CT scans of the chest and abdomen, MRI for brain or spine, and ultrasound for liver, spleen, and kidneys help find deep abscesses, granulomas, and organ enlargement. These scans are very important for planning surgery or drainage and for monitoring long-term damage.

Non-pharmacological treatments (therapies and other supports)

1. Infection-prevention education for the whole family
A simple but powerful “treatment” is teaching patients and families how CGD works, what infections look like and why early medical review matters. Education covers fever checks, wound care, when to seek emergency care and how to use medicines safely. Good understanding has been shown to reduce serious infections in many immune-deficiency conditions by encouraging early treatment and better adherence to prophylaxis plans.

2. Strict hand hygiene and personal cleanliness
Regular hand-washing with soap and water or alcohol gel lowers the number of germs picked up from surfaces, pets and other people. This simple routine before eating, after using the toilet, after touching animals and after outdoor activities reduces bacterial and viral infections, which is especially important when white blood cells cannot kill germs normally, as in CGD.

3. Safe food-handling and “low-risk” diet style
People with Bridges-Good syndrome should follow food-safety rules used for immunocompromised patients: cook meat, poultry, fish and eggs thoroughly, avoid unpasteurized milk and juices, and refrigerate leftovers quickly. These steps lower the risk of food-borne infections like Salmonella or Listeria, which can cause very severe disease in CGD.

4. Avoiding high-risk raw foods
Health agencies advise people with weakened immunity to avoid raw or undercooked meat and fish, raw sprouts, and high-risk unpasteurized cheeses. These foods are more likely to carry dangerous bacteria, and heating them properly is the safest way to eat them. For someone with CGD, limiting these foods is a non-drug way to cut infection risk.

5. Environmental mould and dust avoidance
Many CGD lung infections are caused by Aspergillus fungi found in soil, compost, mulch and rotting leaves. Patients are usually advised not to handle mulch, hay, compost heaps or leaf piles and to avoid dusty building sites. If gardening, wearing gloves and a mask and avoiding high-risk tasks can reduce exposure to fungal spores.

6. Safe water and travel precautions
Using treated tap water, avoiding swallowing pool or lake water and being cautious with street food or untreated water while travelling are important. Immunocompromised people are more likely to become very ill from waterborne infections such as Giardia or certain bacteria, so using bottled or boiled water when quality is uncertain is recommended.

7. Vaccination (within specialist guidance)
Vaccines are a key non-drug prevention tool—inactivated vaccines (like inactivated influenza, pneumococcal, COVID-19, hepatitis B) are generally recommended to lower common infection risks. Live bacterial vaccines (for example BCG) are usually avoided in CGD, so all vaccine decisions must be supervised by an immunology team.

8. Regular specialist follow-up and monitoring
Routine review with an immunologist and infectious-disease specialist allows early detection of lung, liver, bone and gut problems before they become severe. Follow-up often includes blood tests, imaging and discussions about daily life, which helps adjust preventive strategies and improve long-term outcomes in CGD.

9. Early imaging and abscess drainage planning
Because CGD can cause deep abscesses in organs, centres often use early ultrasound or CT scans if a patient has persistent fever or pain. When needed, image-guided drainage or surgical drainage can remove infected collections and reduce the amount of bacteria and pressure, helping antibiotics work better and protecting organ function.

10. Gut-directed therapy and diet for CGD-related colitis
Some people develop inflammatory bowel-disease–like colitis with abdominal pain, diarrhoea and poor growth. Non-pharmacological help includes tailored diets, sometimes elemental or exclusion diets, to reduce gut inflammation, improve nutrient intake and alter the microbiome, often alongside medicines. Clinical trials are exploring dietary interventions for CGD-associated colitis.

11. Physiotherapy and chest clearance
If lungs are affected by repeated infections, chest physiotherapy, breathing exercises and sometimes devices that help loosen mucus can support lung function. Better mucus clearance can reduce bacterial load and improve quality of life in people with chronic lung disease, including those with primary immunodeficiencies.

12. Dental care and mouth hygiene
Gum disease and dental infections can be severe in immunocompromised patients. Regular dental check-ups, careful brushing and flossing, and early treatment of tooth problems help prevent mouth infections spreading into the bloodstream, where they are harder to control in CGD.

13. Psychological support and counselling
Living with a chronic rare disease, frequent hospital visits and infection anxiety can be emotionally difficult. Access to counselling, peer-support groups and mental-health services helps children, teenagers and families cope better, improves adherence to treatment and enhances overall well-being.

14. School, work and lifestyle planning
Non-drug management includes planning safe participation in school or work, adjusting PE or sports, and planning for exams or employment. With good infection-prevention measures and flexible support, many people with CGD can attend mainstream school and work, which is crucial for social and emotional health.

15. Genetic counselling for the family
Because Bridges-Good syndrome is inherited, families benefit from genetic counselling to understand carrier status, future pregnancy options and testing of at-risk relatives. This helps with early diagnosis and informed decisions while also offering emotional support.

16. Infection-alert plans and emergency letters
Many centres give patients a written emergency plan to show to local doctors or emergency departments. It lists the diagnosis, usual prophylactic drugs and recommended first-line antibiotics. This non-pharmacological tool avoids delay or inappropriate treatments during urgent situations.

17. Sunlight and vitamin D-safe outdoor activity
Moderate outdoor activity with sun protection supports bone health, mood and overall fitness. Vitamin D is important for bones and plays a role in immune function, though high-dose supplements show mixed results for infection prevention, so doses should be guided by blood levels and medical advice.

18. Smoking avoidance and clean-air strategies
For CGD, protecting the lungs is critical. Avoiding active and passive smoking, vaping aerosols and heavily polluted environments reduces chronic airway irritation and lowers the risk of respiratory infections and long-term lung damage.

19. Physical activity within safe limits
Regular age-appropriate physical activity helps cardiovascular fitness, mood and bone health. The goal is gentle, consistent exercise adjusted to energy levels, avoiding activities with high risk of cuts, deep soil exposure or heavy dust where possible.

20. Multidisciplinary care (team-based management)
Best outcomes in Bridges-Good syndrome usually come from care at centres with an immunologist, infectious-disease specialist, gastroenterologist, pulmonologist, surgeon, dietitian, psychologist and specialist nurse. Team care coordinates non-drug and drug strategies and ensures smooth transition from childhood to adult services.

---

Drug treatments

Important note: Drug names, classes and typical uses below are educational only. Exact dosing, timing and combinations must always be chosen by a specialist team for each individual patient.

1. Trimethoprim–sulfamethoxazole (TMP-SMX / co-trimoxazole)
This antibiotic combination is the standard daily prophylaxis in CGD to prevent bacterial infections, especially from Staphylococcus aureus and certain Gram-negative bacteria. It is usually taken once or twice daily at a weight-based dose. It blocks folate pathways in bacteria, but human cells are less affected. Side effects can include allergy, rashes, bone-marrow suppression and, rarely, severe reactions such as Stevens–Johnson syndrome or haemophagocytic lymphohistiocytosis, as described in FDA labelling.

2. Itraconazole (oral azole antifungal, e.g. SPORANOX®)
Itraconazole is widely used as antifungal prophylaxis in CGD to prevent invasive Aspergillus and other mould infections. It works by blocking fungal ergosterol synthesis, weakening cell membranes. It is usually given once or twice daily with food; dosing is adjusted by levels and interactions because it strongly inhibits CYP3A4. Side effects include liver-enzyme elevation, heart-failure risk at higher doses and many drug interactions, as highlighted in FDA labels.

3. Posaconazole
Posaconazole is another triazole antifungal sometimes used for prophylaxis or treatment of invasive fungal disease in CGD when itraconazole is not tolerated or fungi are resistant. It has broad activity against Aspergillus and other moulds and is available as delayed-release tablets and liquid. Gastro-intestinal upset and liver-test abnormalities are the main concerns, and drug-level monitoring may be used.

4. Voriconazole
Voriconazole is often chosen for treatment of proven invasive aspergillosis in CGD because of strong activity against Aspergillus species. It can be given intravenously or orally. Important side effects include visual disturbances, photosensitivity, liver-test elevation and drug interactions via CYP450. Careful dosing and levels reduce toxicity while ensuring adequate antifungal action.

5. Amphotericin B (lipid formulations)
Lipid amphotericin B is used for severe or refractory fungal infections. It binds fungal cell-membrane sterols and causes cell death. Lipid forms are preferred because they are less toxic to kidneys than conventional amphotericin B, though infusion reactions, electrolyte disturbances and renal impairment can still occur. In CGD it is reserved for serious, life-threatening fungal disease under close monitoring.

6. Interferon gamma-1b (ACTIMMUNE®)
Interferon gamma-1b is an immune-modulating biologic approved by the FDA to reduce the frequency and severity of serious infections in CGD. It is given as a subcutaneous injection three times per week at a body surface area–based dose, as described in FDA prescribing information. It enhances certain neutrophil and macrophage functions. Common side effects are flu-like symptoms, liver-test changes and reversible bone-marrow suppression.

7. Broad-spectrum intravenous cephalosporins (e.g. cefepime)
When a CGD patient presents with serious bacterial sepsis and the organism is unknown, intravenous cefepime or similar may be used to give rapid Gram-negative and some Gram-positive coverage while cultures are pending. These β-lactam antibiotics inhibit bacterial cell-wall synthesis. Allergy, diarrhoea and Clostridioides difficile infection are key risks.

8. Piperacillin–tazobactam
This combination of an extended-spectrum penicillin and a β-lactamase inhibitor gives strong coverage against many Gram-negative and anaerobic bacteria in abdominal, lung or soft-tissue infections, which are common in CGD. It is given IV several times a day. Allergic reactions, low blood counts and kidney effects can occur, so monitoring is needed.

9. Meropenem or imipenem (carbapenems)
Carbapenem antibiotics are used for severe, resistant or polymicrobial infections, including those involving the abdomen and central nervous system. They inhibit broad-spectrum bacterial cell-wall synthesis. Side effects include seizures (especially with imipenem), diarrhoea and risk of resistant organisms, so use is usually restricted to hospital and specialist input.

10. Ciprofloxacin or levofloxacin (fluoroquinolones)
These oral or IV antibiotics can be used as part of treatment or sometimes prophylaxis for certain Gram-negative infections when culture and sensitivity suggest benefit. They block bacterial DNA gyrase and topoisomerase. Tendon problems, QT prolongation and effects on the microbiome are important safety concerns, especially in younger patients.

11. Vancomycin
For serious suspected or proven MRSA infections, vancomycin is often used as IV therapy. It inhibits Gram-positive bacterial cell-wall synthesis. Dosing is guided by blood levels to balance effect and kidney/ear toxicity. In CGD it is part of combination regimens for severe skin, bone or lung infections.

12. Linezolid
Linezolid is another powerful drug against resistant Gram-positive bacteria and penetrates lungs and bone well. It blocks bacterial protein synthesis. Because it can cause bone-marrow suppression, neuropathy and serotonin-related interactions, it is usually reserved for cases where other options fail or are not tolerated in CGD.

13. Clindamycin
Clindamycin covers many Gram-positive and anaerobic bacteria and is useful for skin, soft-tissue and certain bone infections often seen in CGD. It inhibits protein synthesis, but can cause diarrhoea and C. difficile colitis, so benefits and risks are weighed carefully.

14. Azithromycin
Azithromycin is sometimes used as part of prophylaxis or treatment for respiratory infections and may have modest anti-inflammatory effects in chronic lung disease. It interferes with bacterial protein synthesis and is typically given once daily or three times per week. Common side effects are GI upset and QT-interval prolongation.

15. Corticosteroids (e.g. prednisolone)
Short or carefully controlled courses of oral steroids may be used for granulomatous inflammation in the gut, urinary tract or other organs when it causes obstruction or severe symptoms. They reduce immune-driven inflammation but increase infection risk, so they are always balanced with strong antimicrobial cover and close specialist monitoring.

16. Proton-pump inhibitors and GI protective medicines
Drugs like omeprazole are not specific to CGD but are often used when long courses of NSAIDs, steroids or infections have affected the gut. They lower stomach acid to reduce ulcer risk and reflux. Because changing stomach acidity might influence infection risk, their use is individualised.

17. Antidiarrhoeal and gut-symptom relief medicines
Medications such as loperamide or bile-acid binders are sometimes prescribed to control diarrhoea in CGD-related colitis, but only after infections have been carefully excluded. They help quality of life while disease-specific treatment works but must be monitored to avoid masking serious illness.

18. Analgesics (e.g. paracetamol / acetaminophen)
Pain and fever control with medicines like acetaminophen is important for comfort and functioning. These drugs do not treat the immune defect, but they make infections and post-surgical periods easier to tolerate and can reduce stress on the body. Dose limits and liver function are always respected.

19. Intravenous immunoglobulin (IVIG) in selected cases
IVIG is a pooled antibody preparation sometimes used in patients with CGD who also have antibody deficiencies or recurrent specific infections. It supplies ready-made antibodies to help neutralise pathogens and modulate inflammation. Side effects include headache, thrombosis risk and kidney effects, so it is reserved for clearly defined indications.

20. Supportive drugs (antiemetics, antihistamines, growth and nutrition support)
Because CGD patients often receive complex antibiotic and antifungal regimens, supportive drugs such as antiemetics (for nausea), antihistamines (for allergy) and sometimes nutritional or growth-support medicines are used. These do not treat CGD directly but allow patients to tolerate essential therapies and maintain growth and development.

---

Dietary molecular supplements

Evidence for supplements in CGD is limited; these points come from general immune-health and infection research. Never start high-dose supplements without your specialist.

1. Vitamin D
Vitamin D is crucial for bone health and influences how immune cells work. Studies show mixed results on whether supplements lower respiratory infection risk, but deficiency is clearly harmful. Typical daily needs are around 600 IU in many guidelines, but doses in deficiency are personalised. Too much can cause high calcium, kidney problems and nausea, so blood monitoring is essential.

2. Vitamin C
Vitamin C supports normal collagen formation and acts as an antioxidant. Some data suggest it may slightly shorten common cold duration, but it does not replace antibiotics or prophylaxis in CGD. Usual supplemental doses are 100–500 mg/day; very high doses can cause stomach upset and increase kidney stone risk in susceptible individuals.

3. Zinc
Zinc is vital for normal development and function of many immune cells. Randomised trials in children show zinc supplementation can reduce the duration of diarrhoeal illnesses and some respiratory infections, particularly where zinc deficiency is common. Typical supplement doses are modest (for example 5–20 mg/day, depending on age and diet), as excess can disturb copper balance and cause GI upset.

4. Selenium
Selenium is a trace element used by antioxidant enzymes and immune pathways. In areas with low selenium intake, supplementation has been linked to improved immune responses to some viruses, but data are not CGD-specific. Too much selenium is toxic (hair loss, nail changes, nerve problems), so any supplement should stay within recommended upper limits.

5. Omega-3 fatty acids (e.g. fish oil, EPA/DHA)
Omega-3 fats from fish oil can lower triglycerides and modulate inflammatory responses. Reviews suggest benefits for some inflammatory conditions, but high doses may slightly increase risk of atrial fibrillation and do not clearly prevent heart disease in everyone. Doses often range around 0.5–1 g/day in supplements; in many people, eating oily fish twice per week is preferred.

6. Probiotics
Selected probiotic strains may help restore a healthy gut microbiome and reduce some antibiotic-associated diarrhoea. Evidence in primary immunodeficiency is limited, and there are rare reports of probiotic-related infections in severely immunocompromised individuals, so the choice of strain and timing must be supervised by a specialist, especially in CGD with gut involvement.

7. Folate and vitamin B12
These B vitamins are essential for DNA synthesis and red-blood-cell production. Long-term antibiotic and antifungal use, as well as chronic gut inflammation, can contribute to deficiencies. Supplement doses vary but are usually modest daily tablets or injections for B12 when needed. Correcting deficiency supports energy levels and blood counts but does not repair the NADPH-oxidase defect.

8. Iron (only when clearly deficient)
Iron is needed for haemoglobin and many enzymes, but excess free iron can promote bacterial growth. In CGD, iron supplementation is only used when iron-deficiency anaemia is well documented and other causes are addressed. Doses must be carefully chosen, and intravenous iron is considered with great caution.

9. Turmeric / curcumin (as a food-based supplement)
Curcumin, the main active compound in turmeric, has anti-inflammatory and antioxidant effects in lab and some clinical studies. Research into combinations of turmeric with vitamin D suggests possible immune-modulating benefits, but evidence is still limited and not CGD-specific. Typical supplement doses are 500–1000 mg/day, and high doses may increase bleeding risk or cause reflux.

10. Multivitamin tailored to age and diet
When diet is restricted by illness, a simple age-appropriate multivitamin agreed with the specialist team can help cover small gaps in micronutrients without mega-dosing. This supports overall health and growth while focusing medical treatment on infection prevention and organ protection.

---

Immune-booster, regenerative and stem-cell–related therapies

1. Interferon gamma-1b (immune-modulating biologic)
As mentioned above, interferon gamma-1b is an approved therapy for CGD that reduces serious infections when added to standard antibiotic and antifungal prophylaxis. It acts as an immune “signal” that improves how phagocytes respond to microbes, even though it does not fix the NADPH-oxidase enzyme. It is given as a regular subcutaneous injection and needs monitoring for flu-like symptoms, liver enzymes and blood counts.

2. Granulocyte-colony stimulating factor (G-CSF, e.g. filgrastim) in selected cases
G-CSF is a growth factor that stimulates the bone marrow to produce more neutrophils and is used mainly in neutropenia. In some CGD patients who also have low neutrophil counts or severe infections, short courses may be considered to boost white-cell numbers temporarily. It is given by injection and can cause bone pain and rare spleen-related complications.

3. Intravenous immunoglobulin (IVIG) as an immune modulator
Beyond replacing antibodies, IVIG can modulate immune responses and is sometimes used when there are autoimmune or inflammatory complications overlapping with CGD. It is infused in hospital every few weeks. Side effects include headache, infusion reactions, thrombosis and kidney strain, so it is reserved for specific indications.

4. Allogeneic hematopoietic stem-cell transplantation (HSCT)
HSCT from a healthy donor is currently the only widely used curative option for Bridges-Good syndrome. The patient’s diseased bone marrow is replaced with donor stem cells capable of producing phagocytes with normal oxidative burst. Modern reduced-toxicity conditioning and better graft-versus-host prevention have improved survival significantly, but this remains a major, high-risk procedure done only in specialised centres.

5. Gene therapy with autologous corrected stem cells (investigational)
Several trials are testing lentiviral gene therapy, where a patient’s own stem cells are collected, corrected with a virus carrying a healthy copy of the defective CGD gene and then reinfused after conditioning. Early studies show promising restoration of NADPH-oxidase activity and reduced infections, though long-term safety and durability are still being studied, so this remains a research-only option for now.

6. Supportive regenerative care (nutrition, bone health, organ-protection medicines)
While not “stem-cell drugs”, careful management of nutrition, vitamin D, calcium, and medicines that protect liver and kidney function create a regenerative environment that helps the body recover from repeated infections and intensive treatments. This supportive approach is an essential partner to HSCT or future gene therapies and aims to preserve organ function for the long term.

---

Surgical and procedural treatments

1. Surgical or image-guided drainage of abscesses
Deep abscesses in the liver, spleen, lung or soft tissues are common in CGD. When antibiotics alone cannot clear them, surgeons or interventional radiologists may drain the pus using needles, catheters or open surgery. Removing the infected material reduces bacterial load, relieves pressure and allows antibiotics to work better.

2. Resection of obstructing granulomas in the bowel or urinary tract
Granulomas can narrow or block the intestines, bladder outlet or ureters. In such cases, surgeons may need to remove or bypass the narrowed segment to relieve obstruction, prevent perforation and improve nutrition or kidney function. Surgery is timed and planned carefully with intensive antibiotic and antifungal cover.

3. Lung surgery for localised destructive disease
Rarely, a part of the lung heavily damaged by repeated infections or fungal masses may need surgical removal (segmentectomy or lobectomy) to prevent ongoing infection, bleeding or severe loss of function. This is considered only after detailed imaging and when medical therapies have been maximised.

4. Sinus and ENT procedures
Chronic sinusitis or deep ENT abscesses can be problematic in CGD. ENT surgeons may perform endoscopic sinus surgery or drainage procedures to clear infected material, improve ventilation and reduce recurrent infections, working closely with infectious-disease specialists for tailored antibiotic and antifungal plans.

5. Hematopoietic stem-cell transplantation (as a major procedure)
Although described under regenerative therapies, HSCT is also a complex procedural treatment involving central-line insertion, conditioning chemotherapy, infusion of donor stem cells and long hospital stays. It can offer a functional cure for CGD but carries risks like graft-versus-host disease, infections and organ toxicity. Careful selection, donor search and counselling are essential.

---

Prevention tips

1. Take all prescribed prophylactic medicines exactly as directed – skipping doses increases infection risk even if you feel well.

2. Keep vaccinations up to date with your specialist’s advice, especially inactivated flu, pneumococcal and COVID-19 vaccines.

3. Avoid high-risk environmental exposures such as compost heaps, rotting leaves, dusty barns and building sites whenever possible.

4. Follow food-safety rules: cook animal products fully, avoid unpasteurised dairy and raw sprouts, and refrigerate leftovers promptly.

5. Wash hands often and carry hand gel for times when sinks are not available.

6. Treat even “small” infections early – contact your team quickly for fevers, painful lumps, new cough or gut symptoms.

7. Keep regular specialist appointments and monitoring tests even when feeling well, to catch hidden problems early.

8. Avoid smoking and second-hand smoke to protect lung function.

9. Maintain good sleep, nutrition and activity patterns, which support the immune system and recovery from illness.

10. Share an emergency plan or letter with school, caregivers and local doctors so that everyone knows how to respond if you become unwell.

---

When to see doctors

People with Bridges-Good syndrome should have a low threshold for seeking medical care. Any fever, chills, night sweats, unexplained weight loss, new cough, shortness of breath, severe headache, unusual skin lump, painful swelling, abdominal pain, vomiting, diarrhoea, blood in stool or urine, or difficulty passing urine needs prompt review by a doctor familiar with CGD. Even mild signs can progress quickly because phagocytes cannot kill germs efficiently.

Emergency care should be sought immediately (call local emergency services) for high fever not responding to usual measures, confusion, severe breathing difficulty, chest pain, very bad abdominal pain, inability to drink, signs of sepsis (fast heartbeat, fast breathing, extreme weakness) or any rapid swelling of the face, throat or tongue. In these situations, early intravenous antibiotics and hospital monitoring can be life-saving.

---

What to eat and what to avoid

1. Eat a balanced, energy-rich diet with adequate protein (eggs fully cooked, well-cooked meats, beans), whole grains and healthy fats to support growth, repair and immune function.

2. Choose well-washed or cooked fruits and vegetables; raw produce is fine if thoroughly washed, but cooked options can be safer during intense immune suppression or after HSCT, as advised by your team.

3. Avoid unpasteurised milk, cheese and juices, as these can contain harmful bacteria and, in outbreaks, viruses like avian influenza. Pasteurised products are much safer.

4. Avoid raw or undercooked meat, poultry, seafood and eggs; cook them thoroughly to recommended internal temperatures to kill pathogens.

5. Be cautious with salad bars, delis and buffet foods, which have higher risk of cross-contamination and prolonged room-temperature storage. Freshly prepared, hot food is safer.

6. Store and reheat food safely, refrigerating leftovers within two hours and eating them within a few days to prevent bacterial overgrowth.

7. Drink safe water only, using treated tap water or bottled water. Avoid well water or untreated sources unless tested and approved.

8. Include sources of vitamins and minerals such as fruits, vegetables, nuts (roasted, not raw, if advised), dairy or fortified alternatives, and whole grains to support general health.

9. Limit very sugary drinks and ultra-processed snacks, which add calories but few nutrients and may worsen weight gain, fatty liver or diabetes risk, especially if steroid courses are needed.

10. Always check with your team before starting special diets or supplements, especially extreme restriction diets or herbal products, because they can interact with key antifungal and antibiotic medicines.

---

Frequently asked questions (FAQs)

1. Is Bridges-Good syndrome the same as chronic granulomatous disease (CGD)?
Yes. Bridges-Good syndrome is an older or alternative name for chronic granulomatous disease, a primary immune-deficiency where phagocytes cannot make the reactive oxygen species needed to kill some bacteria and fungi.

2. Can Bridges-Good syndrome be cured?
The underlying genetic problem does not go away by itself. However, hematopoietic stem-cell transplantation can cure CGD in many cases by replacing the bone marrow with donor cells that have normal NADPH-oxidase activity. Research-based gene therapy may offer another curative option in the future.

3. Will every person with CGD need a stem-cell transplant?
No. Some people are managed long term with prophylactic antibiotics, antifungals, interferon gamma-1b and careful infection prevention. Transplant decisions depend on genetics, severity of infections, availability of a suitable donor, other health conditions and the patient’s and family’s preferences.

4. Why is interferon gamma-1b used if it doesn’t fix the enzyme defect?
Interferon gamma-1b does not repair NADPH-oxidase, but it improves how immune cells respond to infection and has been shown in clinical studies and FDA-label information to reduce serious infections in CGD when added to standard prophylaxis.

5. Are live vaccines safe for people with Bridges-Good syndrome?
In general, inactivated vaccines are recommended and safe, while certain live bacterial vaccines (such as BCG) are usually avoided. Some live viral vaccines may be considered depending on the exact immune status. Vaccine plans should always be made by an immunologist who understands the individual’s condition.

6. Can someone with CGD live a normal life span?
Thanks to modern prophylaxis, early infection treatment and options like HSCT, many people with CGD now live much longer and fuller lives than in the past, often attending school, working and starting families. Outcomes vary, so close follow-up and personalised care remain essential.

7. Is CGD always inherited from a parent?
Most cases are inherited, often in an X-linked pattern. Sometimes the mutation arises for the first time (a de-novo variant) in the affected person. Genetic counselling can clarify whether parents are carriers and what the chance is for future children.

8. Can lifestyle changes alone control Bridges-Good syndrome?
No. Lifestyle and non-drug strategies like hygiene and food safety are very important, but they cannot replace prophylactic medicines and urgent treatment of infections. CGD always requires ongoing medical supervision and usually long-term antimicrobial prophylaxis.

9. Are there special tests to diagnose CGD?
Yes. The main modern test is the dihydrorhodamine (DHR) flow cytometry test, which measures the oxidative burst of neutrophils. Genetic testing then identifies the exact gene change. These tests accurately confirm the diagnosis and help in family counselling and transplant planning.

10. Why are fungal infections such a big problem in CGD?
Because NADPH-oxidase–dependent killing is especially important against catalase-positive bacteria and moulds like Aspergillus, people with CGD are more vulnerable to these organisms, especially after exposure to soil, mulch or decaying plant material. Preventive antifungal drugs and environmental precautions are therefore vital.

11. Can children with Bridges-Good syndrome play sports?
Most can take part in non-contact, low-risk sports, avoiding activities with high chance of cuts, dirty wounds or heavy soil exposure. The exact plan should be agreed with the care team and adapted if lung or bone problems occur. Physical activity is generally good for health and mood.

12. Are “immune-boosting” over-the-counter supplements safe?
Many products marketed as immune-boosters have limited evidence and may interact with important medicines or carry infection risks if contaminated. Always discuss any supplement with the specialist team. Focus first on proven measures—prophylaxis, hygiene, food safety and vaccinations.

13. What about pregnancy in someone with CGD or a CGD carrier?
Women with CGD or carriers planning pregnancy should see a genetics and high-risk pregnancy team. Options may include genetic testing of the partner, prenatal diagnosis or pre-implantation genetic testing. Pregnancy care must consider maternal infections and medication safety.

14. Does diet alone fix the immune problem in Bridges-Good syndrome?
No diet can repair the faulty NADPH-oxidase system. However, good nutrition supports growth, organ function and recovery from infection. Special diets may help CGD-related colitis symptoms. Diet is therefore an important support, but not a cure.

15. Where can families find reliable information and support?
Reliable information is available from rare-disease and primary-immunodeficiency organisations, national health sites and patient support groups dedicated to CGD. These groups provide medically reviewed information, community stories and guidance on living with Bridges-Good syndrome.

Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical  history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.

The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members

Last Updated: January 23, 2026.